CRISPR-Based Therapeutics Market - Global Outlook and Forecast 2021-2027

April 2021 | 102 pages | ID: CA03DD2A5E26EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of CRISPR-Based Therapeutics in Global, including the following market information:

Global CRISPR-Based Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global CRISPR-Based Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR-Based Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CRISPR-Based Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global CRISPR-Based Therapeutics Market Segment Percentages, By Type, 2020 (%)

• Genome Editing
• Genetic Engineering
• gRNA Database/Gene Librar
• CRISPR Plasmid
• Human Stem Cells
• Genetically Modified Organisms/Crops
• Cell Line Engineering

China CRISPR-Based Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China CRISPR-Based Therapeutics Market Segment Percentages, By Application, 2020 (%)

• Biotechnology Companies
• Pharmaceutical Companies
• Academic Institutes
• Research and Development Institutes

Global CRISPR-Based Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global CRISPR-Based Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total CRISPR-Based Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total CRISPR-Based Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Caribou Biosciences
• Addgene
• CRISPR THERAPEUTICS
• Merck KGaA
• Mirus Bio LLC
• Editas Medicine
• Takara Bio USA
• Thermo Fisher Scientific
• Horizon Discovery Group
• Intellia Therapeutics
• GE Healthcare Dharmacon

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibody Purification Services Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibody Purification Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODY PURIFICATION SERVICES OVERALL MARKET SIZE

2.1 Global Antibody Purification Services Market Size: 2021 VS 2027
2.2 Global Antibody Purification Services Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antibody Purification Services Players in Global Market
3.2 Top Global Antibody Purification Services Companies Ranked by Revenue
3.3 Global Antibody Purification Services Revenue by Companies
3.4 Top 3 and Top 5 Antibody Purification Services Companies in Global Market, by Revenue in 2020
3.5 Global Companies Antibody Purification Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibody Purification Services Players in Global Market
  3.6.1 List of Global Tier 1 Antibody Purification Services Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antibody Purification Services Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antibody Purification Services Market Size Markets, 2021 & 2027
  4.1.2 Physicochemical Fractionation
  4.1.3 Class-specific Affinity
  4.1.4 Antigen-specific Affinity
4.2 By Type - Global Antibody Purification Services Revenue & Forecasts
  4.2.1 By Type - Global Antibody Purification Services Revenue, 2016-2021
  4.2.2 By Type - Global Antibody Purification Services Revenue, 2022-2027
  4.2.3 By Type - Global Antibody Purification Services Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibody Purification Services Market Size, 2021 & 2027
  5.1.2 Monoclonal Antibodies
  5.1.3 Polyclonal Antibodies
5.2 By Application - Global Antibody Purification Services Revenue & Forecasts
  5.2.1 By Application - Global Antibody Purification Services Revenue, 2016-2021
  5.2.2 By Application - Global Antibody Purification Services Revenue, 2022-2027
  5.2.3 By Application - Global Antibody Purification Services Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Antibody Purification Services Market Size, 2021 & 2027
6.2 By Region - Global Antibody Purification Services Revenue & Forecasts
  6.2.1 By Region - Global Antibody Purification Services Revenue, 2016-2021
  6.2.2 By Region - Global Antibody Purification Services Revenue, 2022-2027
  6.2.3 By Region - Global Antibody Purification Services Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Antibody Purification Services Revenue, 2016-2027
  6.3.2 US Antibody Purification Services Market Size, 2016-2027
  6.3.3 Canada Antibody Purification Services Market Size, 2016-2027
  6.3.4 Mexico Antibody Purification Services Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Antibody Purification Services Revenue, 2016-2027
  6.4.2 Germany Antibody Purification Services Market Size, 2016-2027
  6.4.3 France Antibody Purification Services Market Size, 2016-2027
  6.4.4 U.K. Antibody Purification Services Market Size, 2016-2027
  6.4.5 Italy Antibody Purification Services Market Size, 2016-2027
  6.4.6 Russia Antibody Purification Services Market Size, 2016-2027
  6.4.7 Nordic Countries Antibody Purification Services Market Size, 2016-2027
  6.4.8 Benelux Antibody Purification Services Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Antibody Purification Services Revenue, 2016-2027
  6.5.2 China Antibody Purification Services Market Size, 2016-2027
  6.5.3 Japan Antibody Purification Services Market Size, 2016-2027
  6.5.4 South Korea Antibody Purification Services Market Size, 2016-2027
  6.5.5 Southeast Asia Antibody Purification Services Market Size, 2016-2027
  6.5.6 India Antibody Purification Services Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Antibody Purification Services Revenue, 2016-2027
  6.6.2 Brazil Antibody Purification Services Market Size, 2016-2027
  6.6.3 Argentina Antibody Purification Services Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antibody Purification Services Revenue, 2016-2027
  6.7.2 Turkey Antibody Purification Services Market Size, 2016-2027
  6.7.3 Israel Antibody Purification Services Market Size, 2016-2027
  6.7.4 Saudi Arabia Antibody Purification Services Market Size, 2016-2027
  6.7.5 UAE Antibody Purification Services Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Thermo Fisher
  7.1.1 Thermo Fisher Corporate Summary
  7.1.2 Thermo Fisher Business Overview
  7.1.3 Thermo Fisher Antibody Purification Services Major Product Offerings
  7.1.4 Thermo Fisher Antibody Purification Services Revenue in Global (2016-2021)
  7.1.5 Thermo Fisher Key News
7.2 Detai Bio-Tech Co
  7.2.1 Detai Bio-Tech Co Corporate Summary
  7.2.2 Detai Bio-Tech Co Business Overview
  7.2.3 Detai Bio-Tech Co Antibody Purification Services Major Product Offerings
  7.2.4 Detai Bio-Tech Co Antibody Purification Services Revenue in Global (2016-2021)
  7.2.5 Detai Bio-Tech Co Key News
7.3 Cusabio
  7.3.1 Cusabio Corporate Summary
  7.3.2 Cusabio Business Overview
  7.3.3 Cusabio Antibody Purification Services Major Product Offerings
  7.3.4 Cusabio Antibody Purification Services Revenue in Global (2016-2021)
  7.3.5 Cusabio Key News
7.4 Genscript
  7.4.1 Genscript Corporate Summary
  7.4.2 Genscript Business Overview
  7.4.3 Genscript Antibody Purification Services Major Product Offerings
  7.4.4 Genscript Antibody Purification Services Revenue in Global (2016-2021)
  7.4.5 Genscript Key News
7.5 KMD Bioscience
  7.5.1 KMD Bioscience Corporate Summary
  7.5.2 KMD Bioscience Business Overview
  7.5.3 KMD Bioscience Antibody Purification Services Major Product Offerings
  7.5.4 KMD Bioscience Antibody Purification Services Revenue in Global (2016-2021)
  7.5.5 KMD Bioscience Key News
7.6 SouthernBiotech
  7.6.1 SouthernBiotech Corporate Summary
  7.6.2 SouthernBiotech Business Overview
  7.6.3 SouthernBiotech Antibody Purification Services Major Product Offerings
  7.6.4 SouthernBiotech Antibody Purification Services Revenue in Global (2016-2021)
  7.6.5 SouthernBiotech Key News
7.7 Pacific Immunology
  7.7.1 Pacific Immunology Corporate Summary
  7.7.2 Pacific Immunology Business Overview
  7.7.3 Pacific Immunology Antibody Purification Services Major Product Offerings
  7.4.4 Pacific Immunology Antibody Purification Services Revenue in Global (2016-2021)
  7.7.5 Pacific Immunology Key News
7.8 COVALAB
  7.8.1 COVALAB Corporate Summary
  7.8.2 COVALAB Business Overview
  7.8.3 COVALAB Antibody Purification Services Major Product Offerings
  7.8.4 COVALAB Antibody Purification Services Revenue in Global (2016-2021)
  7.8.5 COVALAB Key News
7.9 Envigo
  7.9.1 Envigo Corporate Summary
  7.9.2 Envigo Business Overview
  7.9.3 Envigo Antibody Purification Services Major Product Offerings
  7.9.4 Envigo Antibody Purification Services Revenue in Global (2016-2021)
  7.9.5 Envigo Key News
7.10 GE Healthcare
  7.10.1 GE Healthcare Corporate Summary
  7.10.2 GE Healthcare Business Overview
  7.10.3 GE Healthcare Antibody Purification Services Major Product Offerings
  7.10.4 GE Healthcare Antibody Purification Services Revenue in Global (2016-2021)
  7.10.5 GE Healthcare Key News
7.11 Rockland
  7.11.1 Rockland Corporate Summary
  7.11.2 Rockland Business Overview
  7.11.3 Rockland Antibody Purification Services Major Product Offerings
  7.11.4 Rockland Antibody Purification Services Revenue in Global (2016-2021)
  7.11.5 Rockland Key News
7.12 Creative Biolabs
  7.12.1 Creative Biolabs Corporate Summary
  7.12.2 Creative Biolabs Business Overview
  7.12.3 Creative Biolabs Antibody Purification Services Major Product Offerings
  7.12.4 Creative Biolabs Antibody Purification Services Revenue in Global (2016-2021)
  7.12.5 Creative Biolabs Key News
7.13 Abcam
  7.13.1 Abcam Corporate Summary
  7.13.2 Abcam Business Overview
  7.13.3 Abcam Antibody Purification Services Major Product Offerings
  7.13.4 Abcam Antibody Purification Services Revenue in Global (2016-2021)
  7.13.5 Abcam Key News
7.14 BBI Solutions
  7.14.1 BBI Solutions Corporate Summary
  7.14.2 BBI Solutions Business Overview
  7.14.3 BBI Solutions Antibody Purification Services Major Product Offerings
  7.14.4 BBI Solutions Antibody Purification Services Revenue in Global (2016-2021)
  7.14.5 BBI Solutions Key News
7.15 Karebay Bio
  7.15.1 Karebay Bio Corporate Summary
  7.15.2 Karebay Bio Business Overview
  7.15.3 Karebay Bio Antibody Purification Services Major Product Offerings
  7.15.4 Karebay Bio Antibody Purification Services Revenue in Global (2016-2021)
  7.15.5 Karebay Bio Key News
7.16 HuaBio
  7.16.1 HuaBio Corporate Summary
  7.16.2 HuaBio Business Overview
  7.16.3 HuaBio Antibody Purification Services Major Product Offerings
  7.16.4 HuaBio Antibody Purification Services Revenue in Global (2016-2021)
  7.16.5 HuaBio Key News
7.17 Antibodies Inc
  7.17.1 Antibodies Inc Corporate Summary
  7.17.2 Antibodies Inc Business Overview
  7.17.3 Antibodies Inc Antibody Purification Services Major Product Offerings
  7.17.4 Antibodies Inc Antibody Purification Services Revenue in Global (2016-2021)
  7.17.5 Antibodies Inc Key News
7.18 Davids Biotechnologie GmbH
  7.18.1 Davids Biotechnologie GmbH Corporate Summary
  7.18.2 Davids Biotechnologie GmbH Business Overview
  7.18.3 Davids Biotechnologie GmbH Antibody Purification Services Major Product Offerings
  7.18.4 Davids Biotechnologie GmbH Antibody Purification Services Revenue in Global (2016-2021)
  7.18.5 Davids Biotechnologie GmbH Key News
7.19 ProSci Inc
  7.19.1 ProSci Inc Corporate Summary
  7.19.2 ProSci Inc Business Overview
  7.19.3 ProSci Inc Antibody Purification Services Major Product Offerings
  7.19.4 ProSci Inc Antibody Purification Services Revenue in Global (2016-2021)
  7.19.5 ProSci Inc Key News
7.20 Bio-Rad
  7.20.1 Bio-Rad Corporate Summary
  7.20.2 Bio-Rad Business Overview
  7.20.3 Bio-Rad Antibody Purification Services Major Product Offerings
  7.20.4 Bio-Rad Antibody Purification Services Revenue in Global (2016-2021)
  7.20.5 Bio-Rad Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. CRISPR-Based Therapeutics Market Opportunities & Trends in Global Market
Table 2. CRISPR-Based Therapeutics Market Drivers in Global Market
Table 3. CRISPR-Based Therapeutics Market Restraints in Global Market
Table 4. Key Players of CRISPR-Based Therapeutics in Global Market
Table 5. Top CRISPR-Based Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global CRISPR-Based Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global CRISPR-Based Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies CRISPR-Based Therapeutics Product Type
Table 9. List of Global Tier 1 CRISPR-Based Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRISPR-Based Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global CRISPR-Based Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - CRISPR-Based Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - CRISPR-Based Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global CRISPR-Based Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - CRISPR-Based Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - CRISPR-Based Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global CRISPR-Based Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global CRISPR-Based Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global CRISPR-Based Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America CRISPR-Based Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe CRISPR-Based Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia CRISPR-Based Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America CRISPR-Based Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa CRISPR-Based Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Caribou Biosciences Corporate Summary
Table 31. Caribou Biosciences CRISPR-Based Therapeutics Product Offerings
Table 32. Caribou Biosciences CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Addgene Corporate Summary
Table 34. Addgene CRISPR-Based Therapeutics Product Offerings
Table 35. Addgene CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. CRISPR THERAPEUTICS Corporate Summary
Table 37. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product Offerings
Table 38. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Merck KGaA Corporate Summary
Table 40. Merck KGaA CRISPR-Based Therapeutics Product Offerings
Table 41. Merck KGaA CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Mirus Bio LLC Corporate Summary
Table 43. Mirus Bio LLC CRISPR-Based Therapeutics Product Offerings
Table 44. Mirus Bio LLC CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Editas Medicine Corporate Summary
Table 46. Editas Medicine CRISPR-Based Therapeutics Product Offerings
Table 47. Editas Medicine CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Takara Bio USA Corporate Summary
Table 49. Takara Bio USA CRISPR-Based Therapeutics Product Offerings
Table 50. Takara Bio USA CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Thermo Fisher Scientific Corporate Summary
Table 52. Thermo Fisher Scientific CRISPR-Based Therapeutics Product Offerings
Table 53. Thermo Fisher Scientific CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Horizon Discovery Group Corporate Summary
Table 55. Horizon Discovery Group CRISPR-Based Therapeutics Product Offerings
Table 56. Horizon Discovery Group CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Intellia Therapeutics Corporate Summary
Table 58. Intellia Therapeutics CRISPR-Based Therapeutics Product Offerings
Table 59. Intellia Therapeutics CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. GE Healthcare Dharmacon Corporate Summary
Table 61. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product Offerings
Table 62. GE Healthcare Dharmacon CRISPR-Based Therapeutics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. CRISPR-Based Therapeutics Segment by Type
Figure 2. CRISPR-Based Therapeutics Segment by Application
Figure 3. Global CRISPR-Based Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global CRISPR-Based Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global CRISPR-Based Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2020
Figure 8. By Type - Global CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 12. US CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 24. China CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa CRISPR-Based Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE CRISPR-Based Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Caribou Biosciences CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Addgene CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck KGaA CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Mirus Bio LLC CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Editas Medicine CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Takara Bio USA CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Thermo Fisher Scientific CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Horizon Discovery Group CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Intellia Therapeutics CRISPR-Based Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)